ESG AND THE CLIMATE ADAPTATION THESIS

---

The platform directly addresses the environmental factors driving the rise of genomic damage, acting as a molecular countermeasure to the Anthropocene:

• Pollution Resilience: Provides the first internal line of defense against chronic, systemic damage from wildfire smoke, industrial particulates, and ozone, which are escalating global health risks.
• UV  Variability: Counteracts the destabilization caused by rising and unpredictable UV intensity, which overwhelms innate repair mechanisms.

We deliver a solution that is restorative and empowering, promoting health equity and countering the pressure toward societal confinement:

• Public Health Crisis: Directly targets the genomic damage that drives the triple-digit rise in skin cancer, the most common cancer globally, addressing a massive and worsening public health burden.
• Enabling a Healthy Relationship with the Sun: By restoring the body’s innate repair capacity, we enable individuals to safely pursue essential outdoor activity, countering the mental and physical health decline associated with forced indoor confinement.
• Non-Optional Access: The technology is framed as essential resilience infrastructure, not a luxury cosmetic, appealing to a broad demographic facing these pervasive threats.

Our commitment to mechanism-defined, small-molecule science ensures transparency and accountability, setting a new bar for the industry:

• Regulatory Leadership: Our mechanism-defined CUL4A platform provides objective, trackable biological outcomes (CPD/6-4PP clearance), establishing a necessary standard of scientific integrity that bypasses the ambiguity of claims-based marketing.
• Supply Chain Purity: Reliance on stable, small molecules ensures predictable, scalable, and non-volatile supply chains, adhering to the highest standards of manufacturing governance.